Intercell partners with GlaxoSmithKline for new needle free technology

GlaxoSmithKline is partnering with Intercell, by providing payments in order to partner for a needle free vaccine technology.

Intercell CEO Gerd Zettlmeissl stated:
"This new partnership is combining the forces of Intercell's innovative needle-free vaccination program and technologies with a vaccine leader's strength in development and commercialization. In addition, we can pursue our business strategy of creating significant shareholder value as an independent company whilst continuing to develop one of the most innovative product pipelines in the industry."

Read more here.

This is the global drug delivery partnerships meeting place, focusing on bringing together professionals seeking the latest strategies, industry updates, and networking opportunities to help position your company for a successful partnership/collaboration. Join us today on LinkedIn or Follow us on Twitter! For more on the Drug Delivery Partnerships event, visit the website: http://bit.ly/6chdrj Download the 2010 Drug Delivery Partnerships Brochure: http://bit.ly/8DRnHv

Share this article with your social network, just click below to share now!

Share |